Posted On: 01/18/2015 1:06:58 PM
Post# of 30074
Re: biotechexpert #15587
Where did he say that? I didn't see AMBS mentioned is his tweet?
Here's what Jason has been saying this month on Amarantus:
Here's what Jason has been saying this month on Amarantus:
Quote:
Our take on the story is that there is simply too much going on at Amarantus to keep the stock under ten cents for much longer.
Quote:
Speaking of credibility, the recent news that the U.S. FDA granted MANF an Orphan Drug designation for Retinitis Pigmentosa (RP) in late December 2014 was a huge win for Amarantus.
Quote:
Amarantus is now loaded with catalysts.
(0)
(0)
